This is a pilot feasibility study and the objective is to evaluate the safety and effectiveness of the investigational device, IN.PACT 014 drug-coated balloon, compared with standard PTA in patients with CLI with CTOs of BTK arteries.
The primary objective of this study was to describe a novel classification system to characterize patterns of failure in deep venous arterialization (DVA) and suggest intervention strategies that correlate with these patterns.
This article seeks to evaluate the effectiveness of the Celt ACD (Vasorum, Ltd) for the closure of antegrade superficial femoral artery access to treat ipsilateral lower-extremity arterial lesions.
C-reactive protein levels may be reduced with long-term administration of ubiquinone (CoQ10) in patients with chronic ischemic heart disease, but the impact of a short-term period of administration in patients undergoing elective vascular surgery is uncertain.
Patients with diabetes and critical limb threatening ischemia (CLTI) are at significantly higher risk of limb loss and death. We evaluate the outcomes of orbital atherectomy (OA) for the treatment of CLTI in patients with and without diabetes.
Our study aim was to investigate the complete wound-healing rate in patients with chronic limb-threatening ischemia after endovascular revascularization, comparing the effectiveness of wound care management by plastic surgeons with other medical specialists.
We performed a meta-analysis of randomized controlled trials investigating the clinical outcomes of patients undergoing percutaneous revascularization with DCB vs percutaneous transluminal angioplasty (PTA) of infrapopliteal arteries.
This study investigates the cost-effectiveness of bypass surgery vs endovascular intervention in CLTI with femoropopliteal lesions.
Our study objective was to explore the potential cost-effectiveness of treatment with the LimFlow pDVA system (LimFlow SA) in the United States healthcare system.
The study objective was to evaluate the safety and efficacy of below-the-ankle intervention in the office-based setting for treatment of chronic limb-threatening ischemia.
The purpose of this study was to investigate the effect of below-the-ankle (BTA) angioplasty on angiographic pedal arch patency and its association with clinical outcomes in patients with chronic critical limb ischemia (CLI).
The study objective is to determine whether selective coronary revascularization following lower-extremity revascularization can improve long-term survival of patients with critical limb threatening ischemia.
Two prespecified literature searches were conducted via Ovid utilizing the following databases: MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews (CDSR). We selected studies reporting amputation-free survival (AFS) in patients with non-revascularizable Rutherford category 5/6 CLI at a minimum follow-up of 6 months.
Despite medical advancements, PAD and CLI continue to increase globally. Treatment for PAD/CLI varies widely and patients with CTOs may be more challenging to treat, requiring specialized crossing techniques and modalities. The objective of this study was to determine the relationship between patients diagnosed with PAD/CLI, with CTOs, and subsequent long-term outcomes.
This randomized, controlled trial was designed to compare the rate of postangiographic contrast-induced nephropathy between the intra-arterial injections of carbon dioxide and the iodinated contrast agent.
Amputation as the initial treatment of choice remains prevalent despite advances in revascularization techniques and medical therapy. We evaluated the 7-year mortality of patients undergoing major and minor lower-extremity amputations and determined the impact of risk factors on long-term mortality.
We review here the mechanism of action of OA, supporting clinical study evidence, and corresponding economic analyses.
This review serves to introduce the most recent data with a factor Xa inhibitor as a novel antithrombotic strategy for PAD.
Previous studies have suggested that Black patients with peripheral artery disease (PAD) may have worse outcomes than White patients. The aim of this study was to determine whether there are racial differences in outcomes of patients with PAD undergoing endovascular treatment.
This analysis seeks to describe the technique of ultrasound-assisted percutaneous superficial femoral arterial access closure with a Mynx device (Cordis Corporation). The study aim was to demonstrate the technical considerations, benefits, efficacy, and safety of this technique.
Below-the-knee peripheral arterial disease more often presents as critical limb ischemia. Endovascular revascularization strategies continue to evolve to achieve long-term limb-salvage outcomes. A single-center experience with optical coherence tomography-guided atherectomy using Pantheris SV (Avinger) is reported.
The Outback device (Cordis) enables true lumen re-entry during subintimal recanalization of CTOs. This study compared outcomes of patients who underwent subintimal recanalization of lower-extremity arterial CTOs utilizing the Outback device via antegrade and retrograde approaches.
The aim of the study was to evaluate the safety and short-term efficacy of the Ranger paclitaxel-coated balloon (PCB; Boston Scientific) in the setting of CLI.
To understand the impact of fluence and repetition rate on outcomes of superficial femoral artery and popliteal artery laser atherectomy based on lesion type (calcific, homogenous, heterogeneous, and restenosis).